" class="no-js "lang="en-US"> Kevin Ballinger - Medtech Alert
Tuesday, April 16, 2024
Kevin Ballinger

Kevin Ballinger

About Kevin Ballinger

Ballinger joined Aldevron from Boston Scientific, a global medical device leader whose products are used in a broad range of interventional medical specialties. He brings 25 years of operating experience, including serving the past nine years as Executive Vice President and Global President of Boston Scientific’s largest division, Interventional Cardiology (IC). As one of Boston Scientific’s most tenured executives, Ballinger helped advance the company’s market leadership, growing the IC division into a $3 billion global business. A native of Minnesota, Ballinger earned his BS in Mechanical Engineering from Michigan Technological University, and his MBA from the University of Minnesota’s Carlson School of Management.

Related Story

Moderna and Aldevron Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline

May 24 2021

Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the […]